Kanada - anglų - Health Canada

glaxosmithkline inc - acyclovir - tablet - 200mg - acyclovir 200mg - nucleosides and nucleotides

Kanada - anglų - Health Canada

glaxosmithkline inc - acyclovir - tablet - 400mg - acyclovir 400mg - nucleosides and nucleotides

Kanada - anglų - Health Canada

glaxosmithkline inc - acyclovir - tablet - 800mg - acyclovir 800mg - nucleosides and nucleotides

Australija - anglų - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - aciclovir -

Airija - anglų - HPRA (Health Products Regulatory Authority)

ltt pharma limited - aciclovir - oral suspension - 200 mg/5ml - nucleosides and nucleotides excl. reverse transcriptase inhibitors; aciclovir

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - aciclovir 5%{relative}; hydrocortisone 1%{relative} - topical cream - active: aciclovir 5%{relative} hydrocortisone 1%{relative} excipient: cetostearyl alcohol citric acid monohydrate hydrochloric acid isopropyl myristate liquid paraffin poloxamer propylene glycol purified water sodium hydroxide sodium laurilsulfate white soft paraffin - zovirax duo is indicated for the treatment of early signs and symptoms of recurrent herpes labialis (cold sores), to reduce the progression of cold sore episodes to ulcerative lesions and to shorten the healing time in immunocompetent adults and adolescents (12 years of age and older).

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

southern cross pharma nz ltd - ganciclovir sodium 543mg equivalent to 500 mg ganciclovir - powder for injection - 500 mg - active: ganciclovir sodium 543mg equivalent to 500 mg ganciclovir - ganciclovir sxp (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease. note: ganciclovir sxp (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

lexon (uk) ltd - aciclovir - cutaneous cream - 50mg/1gram

Singapūras - anglų - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - acyclovir - suspension - 200 mg/5 ml - acyclovir 200 mg/5 ml